source
- Medicare withholds cost data for senior GLP-1 obesity drugs as Massachusetts sues UnitedHealthMedicare announced that seniors can obtain Wegovy and Zepbound for $50 a month starting in July, but the agency has not disclosed how much the program will cost taxpayers. The absence of cost tran…
- Orphan drug sales projected to exceed 21% of prescription market by 2032, driven by strong pipeline and policy supportOrphan drug developers continue to see robust sales growth even as the broader pharmaceutical industry faces pricing and policy turbulence. The latest Evaluate Orphan Drugs Report highlights that s…